Share Prices & Company Research

Market News

20 Jan 2020 | 11:51

FTSE lower in thin trading as Fevertree loses its fizz

UK stocks were trading modestly lower by lunchtime on Monday amid thin trading on a US public holiday, with tonic water maker Fevertree Drinks tanking 25% on the back of disappointing trading update.

At 11.30, the benchmark FTSE 100 index was down 32.25 points, or 0.42%, at 7,642.31, while the FTSE 250 traded 38.4 points lower at 21,847.65.

LARGE AND MID CAP RISERS AND FALLERS

Fevertree Drinks sank 25% to £15 as it warned on profits, after subdued Christmas trading in the UK limited its annual revenue growth to a disappointing 10%.

Defence company BAE Systems rose 2.7% to 641.6p, on announcing that it had agreed to acquire Collins Aerospace's global positioning system business for $1.93bn.

BAE also agreed to acquire Raytheon's airborne tactical radios business for $275m.

Mining company Anglo American edged back 10p to £22.36 as it had made a formal £404.9m takeover bid for Sirius Minerals, which was accepted by the British fertilizer hopeful's board.

Sirius Minerals rose 2.2% to the 5.5p bid price.

SMALL CAP RISERS AND FALLERS

Mall operator Intu Properties slipped 8.6% to 20.9p after it revealed plans to conduct an equity raising.

Economic infrastructure financing specialist Sequoia Economic Infrastructure Fund fell 1.2% to 117.2p, as it too flagged a potential equity raise.

Online women's fashion retailer Sosandar reversed 6.2% to 26.5p, having warned that it would report a deeper-than-expected annual loss despite a jump in revenue, as it continued to invest in customer acquisition.

Waste-to-products group Renewi shed 5.9% to trade at 34.5p after warning that it would record a €25.5m exceptional charge in its annual results, owing to a new Dutch tax and Brexit hurting a key contract in Holland.

Advertising company M&C Saatchi softened 2p to 119p despite guiding for annual underlying profit in line with the downgraded guidance it delivered last month.

The company also said net cash would be least £15m, substantially ahead of expectations, owing to 'improved cash collection processes'.

Immunotherapy developer for cancer Scancell jumped 14.4% to 7.15p after it signed a collaboration and research agreement with a US-based, clinical-stage antibody company that it did not identify.

Cell-based therapies company MaxCyte rallied 9.1% to 132.5p on announcing that it was trading ahead of market expectations, as sales growth accelerated in the second half.

Advice-led wealth manager AFH Financial firmed 3.1% to 397p after reporting strong revenue growth, up 47% to £74.3m for the year to October, and assuring that trading remains strong and in line with the board's expectations.

Story provided by StockMarketWire.com
Get in touch today
Join Redmayne Bentley
Talk to us now about opening a new account or transferring your account from another provider
0113 243 6941
Get in touch today
Contact your local office
Contact your local office to find out more
The value of your investments and the income from them may go down as well as up, and you could get back less than you invested.
We use cookies on this site to improve your experience and help us provide you with a better website. An explanation of the cookies we use and their purpose can be found within our Cookie Policy. Your continued use of this site means you consent to the use of cookies.